CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹20,425 Cr | ₹19,483 Cr | ₹17,763 Cr | ₹17,251 Cr | ₹14,911 Cr |
What is the latest Total Expenditure of CIPLA ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹20,425 Cr |
| Mar2025 | ₹19,483 Cr |
| Mar2024 | ₹17,763 Cr |
| Mar2023 | ₹17,251 Cr |
| Mar2022 | ₹14,911 Cr |
How is Total Expenditure of CIPLA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹20,425 Cr | 4.83 | |
| Mar2025 | ₹19,483 Cr | 9.68 | |
| Mar2024 | ₹17,763 Cr | 2.96 | |
| Mar2023 | ₹17,251 Cr | 15.70 | |
| Mar2022 | ₹14,911 Cr | - | |
Compare Total Expenditure of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹117,813.6 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
| MANKIND PHARMA | ₹104,535.0 Cr | 1.8% | 6.7% | 8% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 0.3% |
6.1% |
-3.7% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses